Case File
efta-01480062DOJ Data Set 10OtherEFTA01480062
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01480062
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
IPM S-ROSFP Signature
(OTC Options Levels S & 6)
Derivative and Foreign Exchange (FX) /Commodity Transactions
Regulated by the Dodd-Frank Wall Street Reform and Consumer
Protection Act (the "Dodd-Frank Act")
IP Morgan
C. Derivatives Approval Level (not applicable for Exempt Transactions)
Level 1: Covered Writing
Level 2: Buying Options
Level 3: Spreads
Level 5: Uncovered Writing
Level 6: Combinations/Straddles
OTC Options
Sel
P°
rt
Please check all that apply:
RI Equity
rx7 Emerging markets
Ff.; Foreign exchange
R. Fixed Income
OVER THE COUNTER (OTC) OPTIONS INCLUDES TRADING OF INTEREST RATESWAPSANO CREDIT °SAULT SWAPS
FORFJGN EXCHANGE OPTIONS INCLUDES TRADING OF NON DelvERAStE PX AND COMMODITY FORWARDS, CONWOODY OPTIONS AND PRECIOUS ME/A'S
D. Acknowledgment
By signing this Agreement, the client acknowledges that: (1) he, she or it requested the derivatives approval level as indicated above and
(2) the client shall promptly advise J.P. Morgan Securities LLC, in writing, of any material changes in his, her or Its financial circumstances
and options investment objectives.
E. Signatures (Ail a
nt owners are required to sign below)
1:: >
(-Signature (Accountholder)
E:D•
)
f
(O1atc )43
JEFFREY E. EPSTEIN
Print Name
Signature (Accountholder)
Date
Print 'Jame
Signature (Accountholder)
Date
Print Name
Signature (Accountholder)
Date
Print Name
3.P. Morgan Use Only
Approvals: I have reviewed the clients suitability profile, including: Investment objectives, Investment experience, and financial condition
and agree that (a) the options level Ind
ed above is appropriate for the client, and (b) if the client has elected to conduct Exempt
Transactions and/or Deny
for the client.
1PM RR Signature
Date
3PM ROSFP Signature
Date
Kf
Date
;
,
J.P. Morgan Use Only
of 5
Title
SPN
Banker/Investor
CAS
6/13 1072
Confidential Treatment Requested by
JPMorgan Chase
CONFIDENTIAL
JPNI-SDNY-00002113
SDNY_GM 00271311
EFTA01480062
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
IPv6
1::Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.